|
Dec 11, 2018
|
Okamoto, K., Ohishi, T., Kuroiwa, M., Iemura, S., Natsume, T. and Seimiya, H. MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs.
Oncotarget, 9, 35844-3585５ (2018)
|
|
Nov 27, 2018
|
Yonekura, R., Osako, T., Iwase, T., Ogiya, A., Ueno, T., Kitagawa, M., Ohno, S. and Akiyama, F. Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast.
Breast Cancer Res. Treat., in press (2018)
|
|
Nov 14, 2018
|
Hatta, T., Iemura, S., Ohishi, T., nakayama, H., Seimiya, H., Iizuka, K., Takeda, J., Natsume, T. and Horikawa, Y. Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.
Sci. Rep., 8, 16756 (2018)
|
|
Oct 16, 2018
|
Yamamoto, T., Sakamoto, C., Tachiwana, H., Kumabe, M., Matsui, T., Yamashita, T., Shinagawa, M., Ochiai, K., Saitoh, N. and Nakao, M. Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.
Sci. Rep., 8, 15202 (2018)
|
|
Oct 05, 2018
|
Fujiwara, C., Muramatsu, Y., Nishii, M., Tokunaka, K., Tahara, H., ueno, M., Yamori, T., Sugimoto, Y. and Seimiya, H. Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Sci. Rep., in press (2018)
|
|
Oct 05, 2018
|
Ma, Y., Tsushima, Y., Sakuma, M., Sasaki, S., Iida, K., Okabe, S., Seimiya, H., Hirokawa, T. and Nagasawa, K. Development of G-quadruplex ligands for selective induction of a parallel-type topology.
Org. Biomol. Chem., in press (2018)
|
|
Oct 05, 2018
|
Mizutani, A., Yashiroda, Y., Muramatsu, Y., Yoshida, H., Chikada, T., Tsumura, T., Okue, M., Shirai, F., Fukami, T., Yoshida, M. and Seimiya, H. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Cancer Sci., in press (2018)
|
|
Sep 20, 2018
|
Ichikawa, Y., Saitoh, N. and Kaufman, P. D. An asymmetric centromeric nucleosome.
Elife, 7, e37911 (2018)
|
|
Sep 12, 2018
|
Kato, Y., Kunimasa, K., Sugimoto, Y. and Tomida, A. BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562 cells.
Biochem. Biophys. Res. Commun., in press (2018)
|
|
Sep 10, 2018
|
Ukaji, T., Takemoto, A., Katayama, R., Takeuchi, K. and Fujita, N. A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis).
Oncotarget, 9, 33322-33336 (2018)
|
|
Sep 03, 2018
|
Nitta, N., Sugimura, T., Isozaki, A., Mikami, H., Hiraki, K., Sakuma, S., Iino, T., Arai, F., Endo, T., Fujiwaki, Y., Fukuzawa, H., Hase, M., Hayakawa, T., Hiramatsu, K., Hoshino, Y., Inaba, M., Ito, T., Karakawa, H., Kasai, Y., Koizumi, K., Lee, S., Lei, C., Li, M., Maeno, T., Matsusaka, S., Murakami, D., Nakagawa, A., Oguchi, Y., Oikawa, M., Ota, T., Shiba, K., Shintaku, H., Shirasaki, Y., Suga, K., Suzuki, Y., Suzuki, N., Tanaka, Y., Tezuka, H., Toyokawa, C., Yalikun, Y., Yamada, M., Yamagishi, M., Yamano, T., Yasumoto, A., Yatomi, Y., Yazawa, M., Di Carlo, D., Hosokawa, Y., Uemura, S., Ozeki, Y. and Goda, K. Intelligent Image-Activated Cell Sorting.
Cell, in press (2018)
|
|
Jul 02, 2018
|
Osumi, H., Shinozaki, E., Mashima, T., Wakatsuki, T., Suenaga, M., Ichimura, T., Ogura, M., Ota, Y., Nakayama, I., Takahari, D., Chin, K., Miki, Y. and Yamaguchi, K. Phase II Trial of Biweekly Cetuximab and Irinotecan as Third-Line Therapy for Pretreated KRAS Exon 2 Wild-Type Colorectal Cancer.
Cancer Sci., in press (2018)
|
|
Jun 28, 2018
|
Koido, M., Tani, Y., Tsukahara, S., Okamoto, Y. and Tomida, A. InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatmen.
Oncotarget, 9, 29097-29111 (2018)
|
|
Jun 22, 2018
|
Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Cremolini, C., Lonardi, S., Bergamo, F., Ning, Y., Yamamoto, N., Okazaki, S., Berger, M. D., Miyamoto, Y., Gopez, R., Barzi, A., Yamaguchi, T., Stinzing, S., Heinemann, V., Loupakis, F., Falcone, A. and Lenz, H. J. Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cance.
Pharmacogenomics J., in press (2018)
|
|
May 24, 2018
|
Ito, K., Ogawa, Y., Yokota, K., Matsumura, S., Minamisawa, T., Suga, K., Shiba, K., Kimura, Y., Hirano-Iwata, A., Takamura, Y. and Ogino, T. Host Cell Prediction of Exosomes Using Morphological Features on Solid Surfaces Analyzed by Machine Learning.
J Phys Chem B, in press (2018)
|
|
May 24, 2018
|
Sakamoto, K., Katayama, R., Asaka, R., Sakata, S., Baba, S., Nakasone, H., Takakuwa, E., Yamazaki, R., Takizawa, J., Maeda, T., Narita, M., Izutsu, K., Kanda, Y., Ohshima, K. and Takeuchi, K. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Leukemia, in press (2018)
|
|
May 21, 2018
|
Takahashi, M. and Hirota, T. Dynamics of sister chromatids through the cell cycle: Together and apart.
Journal of Cell Biology, in press (2018)
|
|
May 10, 2018
|
Gong, B., Oh-Hara, T., Fujita, N. and Katayama, R. 3D culture system containing gellan gum restores oncogene dependence in ROS1 rearrangements non-small cell lung cancer.
Biochem. Biophys. Res. Commun., in press (2018)
|
|
Apr 25, 2018
|
Uchibori, K., Inase, N., Nishio, M., Fujita, N. and Katayama, R. Identification of mutation accumulation as resistance mechanism emerging in first-line osimertinib treatment
J. Thorac. Oncol., in press (2018)
|
|
Apr 18, 2018
|
Tara Bahadur, K. C., Suga, K., Isoshima, T., Aigaki, T., Ito, Y., Shiba, K. and Uzawa, T. Wash-free and selective imaging of epithelial cell adhesion molecule (EpCAM) expressing cells with fluorogenic peptide ligands.
Biochem. Biophys. Res. Commun., in press (2018)
|
|
Apr 16, 2018
|
Dobashi, A., Togashi, Y., Tanaka, N., Yokoyama, M., Tsuyama, N., Baba, S., Mori, S., Hatake, K., Yamaguchi, T., Noda, T. and Takeuchi, K. TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis.
Oncotarget, 9, 19555-19568 (2018)
|
|
Mar 29, 2018
|
Takahashi, A., Loo, T. M., Okada, R., Kamachi, F., Watanabe, Y., Wakita, M., Watanabe, S., Kawamoto, S., Miyata, K., Barber, G. N., Ohtani, N. and Hara, E. Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells.
Nat. Commun., 9, 1249 (2018)
|
|
Mar 16, 2018
|
Kokubun, K., Matsumura, S., Yudasaka, M., Iijima, S. and Shiba, K. Immobilization of a carbon nanomaterial-based localized drug release system using a bispecific material-binding peptide.
Int. J. Nanomedicine, 2018, 1643-1652 (2018)
|
|
Mar 16, 2018
|
Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Ning, Y., Cremolini, C., Antoniotti, C., Borelli, B., Mashima, T., Okazaki, S., Berger, M. D., Miyamoto, Y., Gopez, R., Barzi, A., Lonardi, S., Yamaguchi, T., Falcone, A. and Lenz, H. J. Gene polymorphisms in the CCL5/CCR5 pathway as genetic biomarker for outcome and hand-foot skin reaction in metastatic colorectal cancer patients treated with regorafenib.
Clin. Colorectal Cancer, in press (2018)
|
|
Feb 07, 2018
|
Togashi, Y., Dobashi, A., Sakata, S., Sato, Y., Baba, S., Seto, A., Mitani, H., Kawabata, K. and Takeuchi, K. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
Mod. Pathol., in press (2018)
|
|
Jan 18, 2018
|
Ariyasu, R., Nishikawa, S., Uchibori, K., Oh-Hara, T., Yoshizawa, T., Dotsu, Y., Koyama, J., Saiki, M., Sonoda, T., Kitazono, S., Yanagitani, N., Horiike, A., Inase, N., Kasahara, K., Nishio, M. and Katayama, R. High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer.
Lung Cancer, 117, 1-6 (2018)
|
|
Jan 18, 2018
|
Katayama, R. Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer.
Cancer Sci., in press (2018)
|
